The structural profiles are close, with RB Global carrying a narrow edge on growth. Globus Medical still leads on profitability and valuation, which keeps the comparison from looking entirely one-sided. In the market, Globus Medical carries the stronger setup — intact trend against RB Global's broken trend. That leaves a split case: the structural lead stays with RB Global, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the Russell 1000 universe, making them directly comparable.
Most of the separation is still concentrated in growth.
These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.
This level of similarity points to a meaningful structural match, though not a tight one.
The clearest structural overlap shows up in margin trend and revenue growth trajectory.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The clearest separation appears in growth.
Left means cheaper relative valuation. Higher means stronger structure.
RB Global, Inc. still looks cheaper, even though Globus Medical, Inc. remains structurally stronger.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where GMED and RBA each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
Earnings growth is one contributing factor within the growth lead.
Profitability still favours Globus Medical, with a 7-point operating margin advantage keeping the comparison from looking fully resolved.
Growth is the clearest driver of the lead, with profitability adding further support — though profitability still provides a real counterweight.
Break down the GMED vs RBA comparison across all dimensions with the full interactive tool.
Explore how GMED and RBA each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.